Eosinophil markers in blood, serum, and urine for monitoring the clinical course in childhood asthma: Impact of budesonide treatment and withdrawal

Journal of Allergy and Clinical Immunology

Volumn 107, Issue 5 SUPPL., 2001, Pages 812-817

  Lönnkvist, Karin ^a   Hellman, Cecilia ^a   Lundahl, Joachim ^a   Halldén, Gunilla ^a   Hedlin, Gunilla ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Animal dander allergy; Asthma; Bronchial hyperresponsiveness; Budesonide; Cessation; Children; Eosinophil cationic protein; Eosinophil peroxidase; Eosinophil protein X; Eosinophils; Withdrawal

Indexed keywords

BUDESONIDE; EOSINOPHIL CATIONIC PROTEIN; METHACHOLINE; PEROXIDASE; PLACEBO;

ADOLESCENT; ARTICLE; ASTHMA; BLOOD ANALYSIS; BRONCHUS HYPERREACTIVITY; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DISEASE EXACERBATION; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG WITHDRAWAL; EOSINOPHIL; FEMALE; HUMAN; INFLAMMATION; LUNG FUNCTION; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; URINALYSIS;

EID: 0343831465     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1067/mai.2001.114246     Document Type: Article

References (27)

1. Bousquet J, Chanez P, Lacoste JY, Barneon G, Ghevanian N, Enander I, et al. Eosinophilic inflammation in asthma. N Engl J Med 1990;323:1033-9.
2. Carlson M, Håkansson L, Peterson Stålenheim G, Venge P. Secretion of granulae proteins from eosinophils and neutrophils is increased in asthma. J Allergy Clin Immunol 1991;87:27-33.
3. Janson C, Herala M. Blood eosinophil count as a risk factor for relapse in acute asthma. Respir Med 1992;86:101-4.
4. Hedlin G, Ahlstedt S, Enander I, Håkansson L, Venge P. Eosinophil cationic protein. Chemotactic activity and tryptase in serum before and during bronchial challenge in cat-allergic children with asthma. Pediatr Allergy Immunol 1992;3:144-9.
5. Zimmerman B, Lanner A, Enander I, Zimmerman RS, Peterson CGB, Ahlstedt S. Total blood eosinophils, serum eosinophil cationic protein and eosinophil protein X in childhood asthma: Relation to disease status and therapy. Clin Exp Allergy 1993;23:564-70.
6. Björnsson E, Janson C, Håkansson L, Enander I, Venge P, Boman G. Serum eosinophil cationic protein in relation to bronchial asthma in a young Swedish population. Allergy 1990;49:730-6.
7. Fujisawa T, Terada A, Atsuta J, Iguchi K, Kamiya H, Sakurai M. Clinical utility of serum levels of eosinophil cationic protein (ECP) for monitoring and predicting clinical course of childhood asthma. Clin Exp Allergy 1998;28:19-25.
8. Martinez FD, Stern DA, Wright AL, Taussig LM, Halonen M. Differential immune responses to acute lower respiratory illness in early life by subsequent development of persistent wheezing and asthma. J Allergy Clin Immunol 1998;102:915-20.
9. Kuwasaki T, Chihara J, Kayaba H, Kamata Y, Oyamada H, Saito N, et al. Whole-blood flow-cytometric analysis of eosinophil EG2 expression as a marker of the pathological conditions of asthma. Int Arch Allergy Immunol 1998;177:77-80.
10. Fernvik E, Grönneberg R, Lundahl J, Hed J, Andersson O, Johansson SGO, et al. The degree of natural allergen exposure modifies eosinophil activity markers in the circulation of mild asthmatics. Allergy 1996;51:697-706.
11. Jatakanon A, Lim S, Chung KF, Barnes PJ. An inhaled steroid improves inflammation in patients with mild asthma. Eur Respir J 1998;12:1084-108.
12. Hoekstra MO, Grol MH, Hovenga H, Bouman K, Stijnen T, Koeter GH, et al. Eosinophil and mast cell parameters in children with stable moderate asthma. Pediatr Allergy Immunol 1998;9:143-9.
13. Haahtela T, Järvinen M, Kava T, Kiviranta K, Koskinen S, Lehtonen K, et al. Effects of reducing or discontinuing inhaled budesonide in patients with mild asthma. N Engl J Med 1994;15:700-5.
14. Juniper EF, Kline PA, Vanzieleghem MA, Ramsdale EH, O'Byrne PM, Hargreave FE. Reduction of budesonide after a year of increased use: A randomized controlled trial to evaluate whether improvements in airway responsiveness and clinical asthma are maintained. J Allergy Clin Immunol 1991;87:483-9.
15. Chai H, Farr RS, Froehlich LA, Mathison DA, McLean JA, Rosenthal RR, et al. Standardization of bronchial inhalation challenge procedures. J Allergy Clin Immunol 1975;56:323-7.
16. Carlson MG, Peterson CG, Venge P. Human eosinophil peroxidase: Purification and characterization. J Immunol 1985;134:1875-9.
17. Olsen RL, Little C. Purification and some properties of myeloperoxidase and eosinophil peroxidase from human blood. Biochem J 1983;209:781-7.
18. Halldén G, Hellman C, Grönneberg R, Lundahl J. Increased levels of IL-5 positive peripheral blood eosinophils and lymphocytes in mild asthmatics after allergen inhalation provocation. Clin Exp Allergy 1999;29:595-603.
19. Halldén G, Hed J. The FOG method - a new approach to detecting activated eosinophils. ACI News 1993;5/5:139.
20. Lönnkvist K, Halldén G, Dahlén SE, Enander I, van Hage-Hamsten M, Kumlin M, et al. Markers of inflammation and bronchial reactivity in children with asthma, exposed to animal dander in school dust. Pediatr Allergy Immunol 1999;10:45-52.
21. Wood LJ, Inman MD, Watson RM, Foley R, Denburg JA, O'Byrne PM. Changes in bone marrow inflammatory cell progenitors after inhaled allergen in asthmatic subjects. Am J Respir Crit Care Med 1998;157:99-105.
22. Rubira N, Rodrigo MJ, Pena M, Nogueiras C, Cruz MJ, Cadahia A. Blood sample processing affect on eosinophil concentration on the eosinophil cationic protein concentration. Ann Allergy Asthma Immunol 1997;78:394-8.
23. Halldén G, Nopp A, Ihre E, Peterson CGB, Lundahl J. Conditions in blood sampling procedures that extend the ex vivo stability of eosinophil activity markers in peripheral blood from allergic patients and healthy controls. Ann Allergy Asthma Immunol 1999;83:413-21.
24. Waalkens HJ, Van Essen-Zandvliet EE, Hughes MD, Gerritsen J, Duiverman EJ, KNol K, et al. Cessation of long-term treatment with inhaled corticosteroids (budesonide) in children with asthma results in deterioration. Am Rev Respir Dis 1993;148:1252-7.
25. Wilson JW, Djukanovic R, Howarth PH, Holgate T. Inhaled beclomethasone dipropionate downregulates airway lymphocyte activation in atopic asthma. Am J Respir Crit Care Med 1994;149:86-90.
26. In't Veen JCCM, Smits HH, Hiemstra PS, Zwinderman AE, Sterk PJ, Bel EH. Lung function and sputum characteristics of patients with severe asthma during an induced exacerbation by double-blind steroid withdrawal. Am J Respir Crit Care Med 1999;160:93-9.
27. Gibson PG, Wong BJO, Hepperle MJE, Kline PA, Girgis-Gabardo A, Guyatt G, et al. A research method to induce and examine a mild exacerbation of asthma by withdrawal of inhaled corticosteroids. Clin Exp Allergy 1992;22:525-32.